Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 8Completed 5Unknown 3Terminated 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Lymphoma, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Consolidation Chemotherapy × Clear all
NCT02927938 2022-04-21

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

Wake Forest University Health Sciences

Phase 3 Terminated
18 enrolled 25 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01246752 2021-10-29

AML

University Hospital Carl Gustav Carus

Phase 3 Terminated
143 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00906841 2018-04-27

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

French Innovative Leukemia Organisation

Phase 2 Terminated
75 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡